OneMedNet filed a prospectus related to the offer and resale of up to 11.68M shares of common stock by the selling stockholders. The document outlines the specifics of the proposed transaction involving the company's equity securities.

The prospectus provides regulatory disclosure regarding the shares being offered by the selling stockholders. This filing constitutes the formal registration statement required for the resale of the securities.

Key Details of the Filing

The submission to the SEC covers the mechanics of the share distribution. The offering involves existing shareholders rather than newly issued stock by the company.

The prospectus serves as the primary disclosure document for potential investors reviewing the resale of these shares.

OneMedNet Corporation has secured more than $3 million in new bookings year-to-date for 2026, surpassing the company's total bookings for all of full-year 2025. The company expects to recognize substantially all of these bookings as revenue by the end of the third quarter of 2026. This milestone reflects strong commercial traction for OneMedNet's iRWD™ Platform, powered by Palantir Foundry, as life sciences organizations increasingly utilize its multi-modal, imaging-centric Real-World Data for regulatory submissions and AI model development.

The rapid pace of contracting highlights surging market demand for fit-for-purpose multi-modal datasets and the operational scalability OneMedNet has achieved. This builds on the company's recent milestone of surpassing 90 million patient journeys and 270 million studies across its network of more than 2,300 healthcare partner sites.

Key Highlights

Growth Drivers

The company's growth is driven by new customer wins and expanded engagements with life sciences, medical device, and AI-focused clients. These clients are using the iRWD™ platform for foundation model development, cohort discovery, feasibility studies, and regulatory-grade data delivery. The rapid bookings-to-revenue cycle validates the strength of OneMedNet's data curation, tokenization, and delivery infrastructure.

OneMedNet expects continued momentum in the second half of 2026 as additional pipeline opportunities advance and existing customers deepen their use of the platform. The company is preparing to close out the second quarter with positive tailwinds and enter the second half of the year with strong momentum.